Another good RNS27 Jul 2021 10:29
But I agree that the 'meat on the bones' is still lacking. It's all about reading between the lines which any lth of EUA should be pretty good at by now! It's absolutely true that if the process of focusing on an asset sale had changed (ie come to a halt) that it would have to have been announced. Hence receiving an RNS which doesn't state any such thing is positive. The NOMAD would/could not allow an RNS to be released stating the 'strategy' as in May 12th RNS is proceeding if that weren't the case.
Personally speaking I would prefer to wait longer if they are selling MT until resources are proven up to JORC because only 2.2m oz are so far verified. Inferred will fetch a far lower price and so if the JORC process takes another 3 months then so be it.
I'm not getting too excited about the divi we will end up with just yet as if it ended up being MT sold now then I think the price would be not much above £2b - £3b and I'm fairly confident the BOD are going to hold back quite a chunk of that to progress the JV with Rosgeo. We may end up with just £1b being handed out. Not the sum we're all hoping for but it would still be at a premium of about 75% to the current sp. 75% of your investment back in an instant could certainly be described as 'significant' but probably not 'massive'.
In the mean time we should not be surprised that the sp isn't climbing. We've had far more momentous RNSs that have seen no rise at all, indeed mostly the RNSs over the last 10 months or so - think MT flanks, Tipil license, WK 43% increase in resources, announcement of JV with Rosgeo, iis coming on board at no discount to prevailing sp - have witnessed a drop.
This RNS in my eyes does provide more confidence of an asset sale still proceeding and so I see no reason not to continue holding., or if you're really bold, to top up or increase your holding.
As always GLA